Two CMS Officials: CMS Eyes Excluding Oncology Care Model Practices From Part B Drug Demo

Two CMS officials said Monday (April 11) during separate events that they’re considering excluding doctor practices that are part of the Oncology Care Model from the agency's controversial Part B drug-price demonstration. Last month CMS sparked protests from key stakeholders by proposing to test changes to the physician pay formula in Medicare Part B in a bid to cut prescription drug spending. That proposal has been the subject of multiple public meetings since then, including two on Monday. The Oncology...